ACP
Acuta Capital Partners’s Fulcrum Therapeutics FULC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $410K | Buy |
+59,650
| New | +$410K | 0.57% | 24 |
|
|
2023
Q1 | – | Sell |
-185,000
| Closed | -$1.35M | – | 36 |
|
|
2022
Q4 | $1.35M | Sell |
185,000
-35,000
| -16% | -$255K | 0.83% | 23 |
|
|
2022
Q3 | $1.78M | Buy |
220,000
+20,000
| +10% | +$162K | 0.77% | 28 |
|
|
2022
Q2 | $980K | Hold |
200,000
| – | – | 0.55% | 35 |
|
|
2022
Q1 | $4.73M | Hold |
200,000
| – | – | 2.21% | 16 |
|
|
2021
Q4 | $3.54M | Sell |
200,000
-122,500
| -38% | -$2.17M | 1.49% | 24 |
|
|
2021
Q3 | $9.1M | Sell |
322,500
-281,574
| -47% | -$7.94M | 3.21% | 7 |
|
|
2021
Q2 | $6.33M | Sell |
604,074
-18,426
| -3% | -$193K | 2.53% | 13 |
|
|
2021
Q1 | $7.33M | Sell |
622,500
-60,000
| -9% | -$707K | 2.64% | 16 |
|
|
2020
Q4 | $7.99M | Buy |
682,500
+301,000
| +79% | +$3.52M | 2.17% | 19 |
|
|
2020
Q3 | $3.03M | Buy |
+381,500
| New | +$3.03M | 0.82% | 34 |
|